Decreased Level of sRAGE in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset

Publisher： Karger

E-ISSN： 1423-0216|21|5|226-233

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.21, Iss.5, 2014-03, pp. : 226-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concentration of Soluble Adhesion Molecules (sVCAM-1, sICAM-1 and sL-Selectin) in the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis and Systemic Lupus erythematosus with Central Nervous Involvement

By  

Neuroimmunomodulation, Vol. 9, Iss. 1, 2001-06 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study

By  

Neuroimmunomodulation, Vol. 19, Iss. 5, 2012-03 ,pp. : 277-282

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 20, Iss. 2, 2013-01 ,pp. : 113-118

Karger

Access to resources Recommend Favorite

Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

By  

Neuroimmunomodulation, Vol. 22, Iss. 6, 2015-0 ,pp. : 400-404

Karger

Access to resources Recommend Favorite